ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hog Cholera Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11I14291
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hog Cholera Vaccine Market Research Report 2023
BUY CHAPTERS

Global Hog Cholera Vaccine Market Research Report 2025

Code: QYRE-Auto-11I14291
Report
May 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
CAHIC
Boehringer Ingelheim
WINSUN

Hog Cholera Vaccine Market Size

The global market for Hog Cholera Vaccine was valued at US$ 164 million in the year 2024 and is projected to reach a revised size of US$ 220 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Hog Cholera Vaccine Market

Hog Cholera Vaccine Market

Hog cholera, is a contagious viral disease of domestic and wild swine. 
The hog cholera vaccine market is primarily driven by the need to control and prevent the spread of the highly contagious and economically devastating hog cholera virus (classical swine fever). Vaccination plays a critical role in protecting swine populations and the pig farming industry from this deadly viral disease, which can result in high mortality rates and trade restrictions. The global demand for pork products also fuels the need to ensure the health and well-being of swine herds, making the hog cholera vaccine essential in maintaining a stable and profitable pork supply chain. However, the market also faces challenges, such as the emergence of new strains of the hog cholera virus, which may require the development of updated or novel vaccine formulations. Ensuring the efficacy and safety of vaccines against these evolving strains is crucial to maintain disease control measures. Additionally, the cost of vaccination programs and the accessibility of vaccines to pig farmers, especially in developing regions, can pose obstacles to widespread adoption. Addressing these challenges through continued research and development, international cooperation in disease monitoring, and government support in implementing effective vaccination programs will be essential to drive the growth of the hog cholera vaccine market and protect the swine industry from this significant threat.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hog Cholera Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hog Cholera Vaccine.
The Hog Cholera Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hog Cholera Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hog Cholera Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hog Cholera Vaccine Market Report

Report Metric Details
Report Name Hog Cholera Vaccine Market
Accounted market size in year US$ 164 million
Forecasted market size in 2031 US$ 220 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Government Tender
  • Market Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company WINSUN, Boehringer Ingelheim, CAHIC, Chopper Biology, MSD Animal Health (Merck), ChengDu Tecbond, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory, Ringpu Biology, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, Tecon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hog Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hog Cholera Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hog Cholera Vaccine Market growing?

Ans: The Hog Cholera Vaccine Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Hog Cholera Vaccine Market size in 2031?

Ans: The Hog Cholera Vaccine Market size in 2031 will be US$ 220 million.

Who are the main players in the Hog Cholera Vaccine Market report?

Ans: The main players in the Hog Cholera Vaccine Market are WINSUN, Boehringer Ingelheim, CAHIC, Chopper Biology, MSD Animal Health (Merck), ChengDu Tecbond, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory, Ringpu Biology, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, Tecon

What are the Application segmentation covered in the Hog Cholera Vaccine Market report?

Ans: The Applications covered in the Hog Cholera Vaccine Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Hog Cholera Vaccine Market report?

Ans: The Types covered in the Hog Cholera Vaccine Market report are Tissue Culture Origin, Cell Line Origin

Recommended Reports

Veterinary Vaccines

Livestock Disease Vaccines

Aquaculture & Poultry Vaccines

1 Hog Cholera Vaccine Market Overview
1.1 Product Definition
1.2 Hog Cholera Vaccine by Type
1.2.1 Global Hog Cholera Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tissue Culture Origin
1.2.3 Cell Line Origin
1.3 Hog Cholera Vaccine by Application
1.3.1 Global Hog Cholera Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Hog Cholera Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hog Cholera Vaccine Revenue 2020-2031
1.4.2 Global Hog Cholera Vaccine Sales 2020-2031
1.4.3 Global Hog Cholera Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hog Cholera Vaccine Market Competition by Manufacturers
2.1 Global Hog Cholera Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hog Cholera Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hog Cholera Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hog Cholera Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hog Cholera Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Hog Cholera Vaccine, Date of Enter into This Industry
2.8 Global Hog Cholera Vaccine Market Competitive Situation and Trends
2.8.1 Global Hog Cholera Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hog Cholera Vaccine Players Market Share by Revenue
2.8.3 Global Hog Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hog Cholera Vaccine Market Scenario by Region
3.1 Global Hog Cholera Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hog Cholera Vaccine Sales by Region: 2020-2031
3.2.1 Global Hog Cholera Vaccine Sales by Region: 2020-2025
3.2.2 Global Hog Cholera Vaccine Sales by Region: 2026-2031
3.3 Global Hog Cholera Vaccine Revenue by Region: 2020-2031
3.3.1 Global Hog Cholera Vaccine Revenue by Region: 2020-2025
3.3.2 Global Hog Cholera Vaccine Revenue by Region: 2026-2031
3.4 North America Hog Cholera Vaccine Market Facts & Figures by Country
3.4.1 North America Hog Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hog Cholera Vaccine Sales by Country (2020-2031)
3.4.3 North America Hog Cholera Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hog Cholera Vaccine Market Facts & Figures by Country
3.5.1 Europe Hog Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hog Cholera Vaccine Sales by Country (2020-2031)
3.5.3 Europe Hog Cholera Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hog Cholera Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Hog Cholera Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hog Cholera Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Hog Cholera Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hog Cholera Vaccine Market Facts & Figures by Country
3.7.1 Latin America Hog Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hog Cholera Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Hog Cholera Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hog Cholera Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hog Cholera Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hog Cholera Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hog Cholera Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hog Cholera Vaccine Sales by Type (2020-2031)
4.1.1 Global Hog Cholera Vaccine Sales by Type (2020-2025)
4.1.2 Global Hog Cholera Vaccine Sales by Type (2026-2031)
4.1.3 Global Hog Cholera Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Hog Cholera Vaccine Revenue by Type (2020-2031)
4.2.1 Global Hog Cholera Vaccine Revenue by Type (2020-2025)
4.2.2 Global Hog Cholera Vaccine Revenue by Type (2026-2031)
4.2.3 Global Hog Cholera Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Hog Cholera Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hog Cholera Vaccine Sales by Application (2020-2031)
5.1.1 Global Hog Cholera Vaccine Sales by Application (2020-2025)
5.1.2 Global Hog Cholera Vaccine Sales by Application (2026-2031)
5.1.3 Global Hog Cholera Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Hog Cholera Vaccine Revenue by Application (2020-2031)
5.2.1 Global Hog Cholera Vaccine Revenue by Application (2020-2025)
5.2.2 Global Hog Cholera Vaccine Revenue by Application (2026-2031)
5.2.3 Global Hog Cholera Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Hog Cholera Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 WINSUN
6.1.1 WINSUN Company Information
6.1.2 WINSUN Description and Business Overview
6.1.3 WINSUN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 WINSUN Hog Cholera Vaccine Product Portfolio
6.1.5 WINSUN Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Hog Cholera Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Company Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CAHIC Hog Cholera Vaccine Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Chopper Biology
6.4.1 Chopper Biology Company Information
6.4.2 Chopper Biology Description and Business Overview
6.4.3 Chopper Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chopper Biology Hog Cholera Vaccine Product Portfolio
6.4.5 Chopper Biology Recent Developments/Updates
6.5 MSD Animal Health (Merck)
6.5.1 MSD Animal Health (Merck) Company Information
6.5.2 MSD Animal Health (Merck) Description and Business Overview
6.5.3 MSD Animal Health (Merck) Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MSD Animal Health (Merck) Hog Cholera Vaccine Product Portfolio
6.5.5 MSD Animal Health (Merck) Recent Developments/Updates
6.6 ChengDu Tecbond
6.6.1 ChengDu Tecbond Company Information
6.6.2 ChengDu Tecbond Description and Business Overview
6.6.3 ChengDu Tecbond Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ChengDu Tecbond Hog Cholera Vaccine Product Portfolio
6.6.5 ChengDu Tecbond Recent Developments/Updates
6.7 Ceva
6.7.1 Ceva Company Information
6.7.2 Ceva Description and Business Overview
6.7.3 Ceva Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Hog Cholera Vaccine Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Harbin Veterinary Research Institute
6.8.1 Harbin Veterinary Research Institute Company Information
6.8.2 Harbin Veterinary Research Institute Description and Business Overview
6.8.3 Harbin Veterinary Research Institute Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Harbin Veterinary Research Institute Hog Cholera Vaccine Product Portfolio
6.8.5 Harbin Veterinary Research Institute Recent Developments/Updates
6.9 Qilu Animal Health Products Factory
6.9.1 Qilu Animal Health Products Factory Company Information
6.9.2 Qilu Animal Health Products Factory Description and Business Overview
6.9.3 Qilu Animal Health Products Factory Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Qilu Animal Health Products Factory Hog Cholera Vaccine Product Portfolio
6.9.5 Qilu Animal Health Products Factory Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Company Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ringpu Biology Hog Cholera Vaccine Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 DHN
6.11.1 DHN Company Information
6.11.2 DHN Description and Business Overview
6.11.3 DHN Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 DHN Hog Cholera Vaccine Product Portfolio
6.11.5 DHN Recent Developments/Updates
6.12 CAVAC
6.12.1 CAVAC Company Information
6.12.2 CAVAC Description and Business Overview
6.12.3 CAVAC Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CAVAC Hog Cholera Vaccine Product Portfolio
6.12.5 CAVAC Recent Developments/Updates
6.13 Komipharm
6.13.1 Komipharm Company Information
6.13.2 Komipharm Description and Business Overview
6.13.3 Komipharm Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Komipharm Hog Cholera Vaccine Product Portfolio
6.13.5 Komipharm Recent Developments/Updates
6.14 Agrovet
6.14.1 Agrovet Company Information
6.14.2 Agrovet Description and Business Overview
6.14.3 Agrovet Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Agrovet Hog Cholera Vaccine Product Portfolio
6.14.5 Agrovet Recent Developments/Updates
6.15 Bioveta
6.15.1 Bioveta Company Information
6.15.2 Bioveta Description and Business Overview
6.15.3 Bioveta Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Bioveta Hog Cholera Vaccine Product Portfolio
6.15.5 Bioveta Recent Developments/Updates
6.16 Jinyu Bio-Technology
6.16.1 Jinyu Bio-Technology Company Information
6.16.2 Jinyu Bio-Technology Description and Business Overview
6.16.3 Jinyu Bio-Technology Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Jinyu Bio-Technology Hog Cholera Vaccine Product Portfolio
6.16.5 Jinyu Bio-Technology Recent Developments/Updates
6.17 Institutul Pasteur
6.17.1 Institutul Pasteur Company Information
6.17.2 Institutul Pasteur Description and Business Overview
6.17.3 Institutul Pasteur Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Institutul Pasteur Hog Cholera Vaccine Product Portfolio
6.17.5 Institutul Pasteur Recent Developments/Updates
6.18 MVP
6.18.1 MVP Company Information
6.18.2 MVP Description and Business Overview
6.18.3 MVP Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 MVP Hog Cholera Vaccine Product Portfolio
6.18.5 MVP Recent Developments/Updates
6.19 Tecon
6.19.1 Tecon Company Information
6.19.2 Tecon Description and Business Overview
6.19.3 Tecon Hog Cholera Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Tecon Hog Cholera Vaccine Product Portfolio
6.19.5 Tecon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hog Cholera Vaccine Industry Chain Analysis
7.2 Hog Cholera Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hog Cholera Vaccine Production Mode & Process Analysis
7.4 Hog Cholera Vaccine Sales and Marketing
7.4.1 Hog Cholera Vaccine Sales Channels
7.4.2 Hog Cholera Vaccine Distributors
7.5 Hog Cholera Vaccine Customer Analysis
8 Hog Cholera Vaccine Market Dynamics
8.1 Hog Cholera Vaccine Industry Trends
8.2 Hog Cholera Vaccine Market Drivers
8.3 Hog Cholera Vaccine Market Challenges
8.4 Hog Cholera Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
CAHIC
Boehringer Ingelheim
WINSUN
List of Tables
 Table 1. Global Hog Cholera Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hog Cholera Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hog Cholera Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hog Cholera Vaccine Sales (M Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hog Cholera Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hog Cholera Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hog Cholera Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hog Cholera Vaccine Average Price (US$/K Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hog Cholera Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hog Cholera Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hog Cholera Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Hog Cholera Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hog Cholera Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hog Cholera Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hog Cholera Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hog Cholera Vaccine Sales by Region (2020-2025) & (M Units)
 Table 18. Global Hog Cholera Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Hog Cholera Vaccine Sales by Region (2026-2031) & (M Units)
 Table 20. Global Hog Cholera Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Hog Cholera Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hog Cholera Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Hog Cholera Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hog Cholera Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Hog Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hog Cholera Vaccine Sales by Country (2020-2025) & (M Units)
 Table 27. North America Hog Cholera Vaccine Sales by Country (2026-2031) & (M Units)
 Table 28. North America Hog Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hog Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hog Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hog Cholera Vaccine Sales by Country (2020-2025) & (M Units)
 Table 32. Europe Hog Cholera Vaccine Sales by Country (2026-2031) & (M Units)
 Table 33. Europe Hog Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hog Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hog Cholera Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hog Cholera Vaccine Sales by Region (2020-2025) & (M Units)
 Table 37. Asia Pacific Hog Cholera Vaccine Sales by Region (2026-2031) & (M Units)
 Table 38. Asia Pacific Hog Cholera Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hog Cholera Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hog Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hog Cholera Vaccine Sales by Country (2020-2025) & (M Units)
 Table 42. Latin America Hog Cholera Vaccine Sales by Country (2026-2031) & (M Units)
 Table 43. Latin America Hog Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hog Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hog Cholera Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hog Cholera Vaccine Sales by Country (2020-2025) & (M Units)
 Table 47. Middle East and Africa Hog Cholera Vaccine Sales by Country (2026-2031) & (M Units)
 Table 48. Middle East and Africa Hog Cholera Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hog Cholera Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hog Cholera Vaccine Sales (M Units) by Type (2020-2025)
 Table 51. Global Hog Cholera Vaccine Sales (M Units) by Type (2026-2031)
 Table 52. Global Hog Cholera Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Hog Cholera Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Hog Cholera Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hog Cholera Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hog Cholera Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Hog Cholera Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2020-2025)
 Table 59. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2026-2031)
 Table 60. Global Hog Cholera Vaccine Sales (M Units) by Application (2020-2025)
 Table 61. Global Hog Cholera Vaccine Sales (M Units) by Application (2026-2031)
 Table 62. Global Hog Cholera Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Hog Cholera Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Hog Cholera Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hog Cholera Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hog Cholera Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Hog Cholera Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2020-2025)
 Table 69. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2026-2031)
 Table 70. WINSUN Company Information
 Table 71. WINSUN Description and Business Overview
 Table 72. WINSUN Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 73. WINSUN Hog Cholera Vaccine Product
 Table 74. WINSUN Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Hog Cholera Vaccine Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. CAHIC Company Information
 Table 81. CAHIC Description and Business Overview
 Table 82. CAHIC Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 83. CAHIC Hog Cholera Vaccine Product
 Table 84. CAHIC Recent Developments/Updates
 Table 85. Chopper Biology Company Information
 Table 86. Chopper Biology Description and Business Overview
 Table 87. Chopper Biology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 88. Chopper Biology Hog Cholera Vaccine Product
 Table 89. Chopper Biology Recent Developments/Updates
 Table 90. MSD Animal Health (Merck) Company Information
 Table 91. MSD Animal Health (Merck) Description and Business Overview
 Table 92. MSD Animal Health (Merck) Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 93. MSD Animal Health (Merck) Hog Cholera Vaccine Product
 Table 94. MSD Animal Health (Merck) Recent Developments/Updates
 Table 95. ChengDu Tecbond Company Information
 Table 96. ChengDu Tecbond Description and Business Overview
 Table 97. ChengDu Tecbond Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 98. ChengDu Tecbond Hog Cholera Vaccine Product
 Table 99. ChengDu Tecbond Recent Developments/Updates
 Table 100. Ceva Company Information
 Table 101. Ceva Description and Business Overview
 Table 102. Ceva Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 103. Ceva Hog Cholera Vaccine Product
 Table 104. Ceva Recent Developments/Updates
 Table 105. Harbin Veterinary Research Institute Company Information
 Table 106. Harbin Veterinary Research Institute Description and Business Overview
 Table 107. Harbin Veterinary Research Institute Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 108. Harbin Veterinary Research Institute Hog Cholera Vaccine Product
 Table 109. Harbin Veterinary Research Institute Recent Developments/Updates
 Table 110. Qilu Animal Health Products Factory Company Information
 Table 111. Qilu Animal Health Products Factory Description and Business Overview
 Table 112. Qilu Animal Health Products Factory Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 113. Qilu Animal Health Products Factory Hog Cholera Vaccine Product
 Table 114. Qilu Animal Health Products Factory Recent Developments/Updates
 Table 115. Ringpu Biology Company Information
 Table 116. Ringpu Biology Description and Business Overview
 Table 117. Ringpu Biology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 118. Ringpu Biology Hog Cholera Vaccine Product
 Table 119. Ringpu Biology Recent Developments/Updates
 Table 120. DHN Company Information
 Table 121. DHN Description and Business Overview
 Table 122. DHN Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 123. DHN Hog Cholera Vaccine Product
 Table 124. DHN Recent Developments/Updates
 Table 125. CAVAC Company Information
 Table 126. CAVAC Description and Business Overview
 Table 127. CAVAC Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 128. CAVAC Hog Cholera Vaccine Product
 Table 129. CAVAC Recent Developments/Updates
 Table 130. Komipharm Company Information
 Table 131. Komipharm Description and Business Overview
 Table 132. Komipharm Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 133. Komipharm Hog Cholera Vaccine Product
 Table 134. Komipharm Recent Developments/Updates
 Table 135. Agrovet Company Information
 Table 136. Agrovet Description and Business Overview
 Table 137. Agrovet Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 138. Agrovet Hog Cholera Vaccine Product
 Table 139. Agrovet Recent Developments/Updates
 Table 140. Bioveta Company Information
 Table 141. Bioveta Description and Business Overview
 Table 142. Bioveta Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 143. Bioveta Hog Cholera Vaccine Product
 Table 144. Bioveta Recent Developments/Updates
 Table 145. Jinyu Bio-Technology Company Information
 Table 146. Jinyu Bio-Technology Description and Business Overview
 Table 147. Jinyu Bio-Technology Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 148. Jinyu Bio-Technology Hog Cholera Vaccine Product
 Table 149. Jinyu Bio-Technology Recent Developments/Updates
 Table 150. Institutul Pasteur Company Information
 Table 151. Institutul Pasteur Description and Business Overview
 Table 152. Institutul Pasteur Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 153. Institutul Pasteur Hog Cholera Vaccine Product
 Table 154. Institutul Pasteur Recent Developments/Updates
 Table 155. MVP Company Information
 Table 156. MVP Description and Business Overview
 Table 157. MVP Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 158. MVP Hog Cholera Vaccine Product
 Table 159. MVP Recent Developments/Updates
 Table 160. Tecon Company Information
 Table 161. Tecon Description and Business Overview
 Table 162. Tecon Hog Cholera Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2020-2025)
 Table 163. Tecon Hog Cholera Vaccine Product
 Table 164. Tecon Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Hog Cholera Vaccine Distributors List
 Table 168. Hog Cholera Vaccine Customers List
 Table 169. Hog Cholera Vaccine Market Trends
 Table 170. Hog Cholera Vaccine Market Drivers
 Table 171. Hog Cholera Vaccine Market Challenges
 Table 172. Hog Cholera Vaccine Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hog Cholera Vaccine
 Figure 2. Global Hog Cholera Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hog Cholera Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Tissue Culture Origin Product Picture
 Figure 5. Cell Line Origin Product Picture
 Figure 6. Global Hog Cholera Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hog Cholera Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Government Tender
 Figure 9. Market Sales
 Figure 10. Global Hog Cholera Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Hog Cholera Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Hog Cholera Vaccine Sales (2020-2031) & (M Units)
 Figure 13. Global Hog Cholera Vaccine Average Price (US$/K Unit) & (2020-2031)
 Figure 14. Hog Cholera Vaccine Report Years Considered
 Figure 15. Hog Cholera Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Hog Cholera Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Hog Cholera Vaccine Players: Market Share by Revenue in Hog Cholera Vaccine in 2024
 Figure 18. Hog Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Hog Cholera Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Hog Cholera Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Hog Cholera Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Hog Cholera Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Hog Cholera Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Hog Cholera Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Hog Cholera Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Hog Cholera Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Hog Cholera Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Hog Cholera Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Hog Cholera Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Hog Cholera Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Hog Cholera Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Hog Cholera Vaccine by Type (2020-2031)
 Figure 53. Global Hog Cholera Vaccine Price (US$/K Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Hog Cholera Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Hog Cholera Vaccine by Application (2020-2031)
 Figure 56. Global Hog Cholera Vaccine Price (US$/K Unit) by Application (2020-2031)
 Figure 57. Hog Cholera Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Swine Fever Vaccine Market Insights Forecast to 2030
Swine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Epidemic Diarrhea Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Classical Swine Fever Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Insights Forecast to 2030
Oral Live Cholera Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Streptococcus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Swine Circovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholera Vaccines Oral Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Porcine Circovirus Diseases Vaccine Market Research Report 2024
Swine Mycoplasma Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Classical Swine Fever Vaccines Market Research Report 2025
Global Porcine Transmissible Gastroenteritis and Epidemic Diarrhea Dual Vaccine Market Research Report 2024
Global Oral Cholera Vaccine Market Research Report 2025
Global Animal Vaccines Market Insights Forecast to 2030
Global Hogs Market Research Report 2025
Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Porcine Medicine and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions